糖尿病血糖变异性:临床与治疗意义
血糖变异性是血糖稳态的组成部分,尚未被确认为糖尿病并发症的独立危险因素,但可反映血糖波动过度及高血糖或低血糖风险。本文综述了血糖变异性与糖尿病相关并发症关联的最新证据,以及当前可用的非药物和药物干预策略。
要点
- 血糖变异性尚未被确认为糖尿病并发症的独立危险因素。
- 血糖变异性可反映血糖波动过度及高血糖或低血糖风险。
- 血糖变异性指标包括短期(日内和日间)和长期变异性。
核心结论
- 血糖变异性尚未被确认为糖尿病并发症的独立危险因素,但可反映血糖波动过度及高血糖或低血糖风险。
研究设计与样本
- 本文为综述,讨论近期关于血糖变异性与糖尿病相关并发症关联的证据及现有干预策略。
主要发现
- 血糖变异性是血糖稳态的组成部分,可代表血糖波动过度及高血糖或低血糖风险。
- 血糖变异性由大量且不断增加的指标定义,包括短期(日内和日间)和长期变异性。
- 长期血糖变异性通常基于系列HbA1c测量或较长时间内其他血糖指标。
关键数值与推荐
- 短期血糖变异性包括日内和日间变异性。
- 长期血糖变异性通常基于系列HbA1c测量或较长时间内其他血糖指标。
临床怎么用
- 综述讨论了当前可用的非药物和药物策略以应对血糖变异性这一糖尿病管理中的挑战。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glycaemic variability is an integral component of glucose homoeostasis. Although it has not yet been definitively confirmed as an independent risk factor for diabetes complications, glycaemic variability can represent the presence of excess glycaemic excursions and, consequently, the risk of hyperglycaemia or hypoglycaemia. Glycaemic variability is currently defined by a large and increasing number of metrics, representing either short-term (within-day and between-day variability) or long-term glycaemic variability, which is usually based on serial measurements of HbA1c or other measures of glycaemia over a longer period of time. In this Review, we discuss recent evidence examining the association between glycaemic variability and diabetes-related complications, as well as non-pharmacological and pharmacological strategies currently available to address this challenging aspect of diabetes management.
引用
- Ceriello A, Monnier L, Owens D, et al. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2018. PMID: 30115599. doi:10.1016/S2213-8587(18)30136-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。